CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Other events
- 4 Open-market buy Director bought 56,818 shares at $0.88 ($50,000)
- 4 Open-market buy Director bought 11,000 shares at $0.89 ($9,840)
- 4 Planned sale CFO and Chief Corp. Dev. Off sold 45,887 shares at $0.90 ($41,147)
- 4 Planned sale Chief Medical Officer sold 45,887 shares at $0.90 ($41,147)
Page 2 of 26 · 506 filings